Job Trends
The scenery will continue to change for GlaxoSmithKline as the company’s planned demerger looms on the horizon. On Monday, GSK gave a glimpse of where the companies will call home post-split.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
Looking for a biopharma job in Boston? Check out the BioSpace list of six companies hiring life sciences professionals like you.
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
THE LATEST
To help kick off the holiday season, BioSpace gave this Christmas classic a unique biopharma spin.
It was, as usual, a pretty busy week in clinical trial news. Here’s a look.
The Career Conversation Forum, part of the February 19-20, 2020 Life Science Women’s Conference at the Tampa Convention Center, will present women at all stages of their life science career, or those interested in life sciences, with information on career paths, salary expectations, and day-to-day activities from women who have these experiences.
Plasmid DNA Manufacturer VGXI, Inc. Selects BE&K Building Group as its Design-Build Partner for the Initial Phase of its New and Expanded Manufacturing Facility
InDevR, Inc., a life science tools company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced that Ms. Terry Salyer has joined the company as Chief Commercial Officer.
Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can fuel cancer development and suppress immune response to the disease.
AstraZeneca inked a deal with Germany-based Cheplapharm Arzneimittel GmbH to sell the commercial rights to Seroquel and Seroquel XR in the U.S. and Canada.
Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, announced that it will participate in the Piper Jaffray 31st Annual Healthcare Conference in New York, NY.
Combination of Prexigebersen and Decitabine Showed Encouraging Safety and Efficacy Results